Docosatetraenylethanolamide

Overview

Docosatetraenylethanolamide (DEA) is a cannabinoid receptor 1 ( CB1 ) agonist. Docosatetraenylethanolamide inhibits the specific binding of cannabinoid probe to rat synaptosomal membranes with a K i value of 34.4 nM. Docosatetraenylethanolamide can be used in the research of nervous system.

Application

Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Neuronal Signaling | Products > Signaling Pathways > GPCR/G Protein | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > Endogenous Metabolite | Products > Signaling Pathways > Cannabinoid Receptor

Product Information

• Catalog No.: HY-110016
• CAS No.: 150314-35-5
• Molecular Formula: C24H41NO2
• Molecular Weight: 375.59
• Purity: 98.00%
• Storage: Solution, -20°C, 2 years
• Availability: In-stock

Source

Original product source